Ikris Pharma Network

Ikris Pharma Network (IPN) is a global pharmaceutical access partner providing structured, compliant access to specialty, rare disease, and hard-to-source medicines worldwide. Combining regulatory expertise, global procurement, clinical research support, and patient access solutions, we remove geographical and regulatory barriers to ensure hospitals and patients receive essential therapies with full compliance. Our Core Services Named Patient & Managed Access Programs: We facilitate regulatory-compliant access to unapproved or unavailable medicines through Named Patient Programs. Global Medicine Export & Specialty Sourcing: IPN provides access to affordable and high-quality medicines sourced exclusively from global markets. Clinical Trial Supply & Comparator (RLD) Sourcing: We support sponsors, CROs, and research institutions with reliable sourcing and distribution of RLDs and comparators. Rare Disease Access Solutions: We specialize in enabling compliant access to therapies for rare and complex diseases worldwide. Real-World Data (RWD) Support: We support healthcare stakeholders with real-world data insights to strengthen evidence generation and improve patient outcomes. Why IPN? IPN is a strategic global access partner. We combine: Regulatory intelligence International procurement networks Rare disease expertise Clinical supply capabilities Compliance-focused logistics Real-world data support With offices in Bulgaria, Belgium, Hong Kong, and India, we deliver verified, compliant access pathways worldwide. Key Highlights Global Pharmaceutical Access Leader – Trusted global sourcing and export Rare Disease Expertise – Access to orphan and hard-to-find therapies Named Patient Programs Excellence – Transparent, documented access solutions Clinical Trial Supply Partner – Reliable comparator & RLD sourcing Real-World Data (RWD) Support – Evidence-driven access strategies Dedicated Compliance & Logistics – Regulatory alignment with operational excellence